BIO-PATH HOLDINGS REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS

Bio-Path Holdings to Announce Second Quarter 2019 Financial Results on August 15, 2019

BIO-PATH HOLDINGS REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS

Bio-Path Holdings to Announce First Quarter 2019 Financial Results on May 16, 2019

Bio-Path Holdings Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2019 — Highlighting Important Cancer Gene, STAT3, Therapeutic Strategy in Pancreatic, Non-Small Cell Lung Cancers and Acute Myelogenous Leukemia

BIO-PATH HOLDINGS REPORTS FULL YEAR 2018 FINANCIAL RESULTS: Conference Call to be Held Today at 8:30 a.m. ET

Bio-Path Holdings to Announce Fourth Quarter and Full Year 2018 Financial Results on March 20, 2019

Bio-Bio-Path Holdings, Inc. Announces Closing of $18.5 Million Registered Direct Offering of Common Stock

Bio-Path Holdings, Inc. Announces $18.5 Million Registered Direct Offering of Common Stock

Bio-Path Announces Clinical Update to Interim Analysis of Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia